AstraZeneca AZN-Q laid out plans on Monday to directly list its shares in the United States, as the drugmaker seeks to maximize gains from its biggest market and investor pool, even as it said that it was not exiting London. The decision to remain U.K.-based will be of some relief to…This story appeared on theglobeandmail.com , 2025-09-29 11:02:44.